TIM-3 pathway dysregulation and targeting in cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TIM-3 pathway dysregulation and targeting in cancer

Published:2021-01-19 Issue:5 Volume:21 Page:523-534
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Zeidan Amer M¹,Komrokji Rami S²,Brunner Andrew M³

Affiliation:

1. Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT, USA

2. Malignant Hematology Department, Moffitt Cancer Center and Research Institute, Tampa, FL, USA

3. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA

Funder

Larra Yueling

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2021.1865814

Reference120 articles.

1. Immune evasion in cancer: Mechanistic basis and therapeutic strategies

2. The blockade of immune checkpoints in cancer immunotherapy

3. Immune checkpoint receptors: homeostatic regulators of immunity

4. Immune checkpoint inhibitors: recent progress and potential biomarkers

5. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Checkpoint inhibition in hematologic malignancies;Frontiers in Oncology;2024-06-03

2. Knocking down of Xkr8 enhances chemotherapy efficacy through modulating tumor immune microenvironment;Journal of Controlled Release;2024-06

3. Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?;Cells;2024-06-01

4. Immune checkpoint inhibitors: breakthroughs in cancer treatment;Cancer Biology & Medicine;2024-05-24

5. High-multiplex single-cell imaging analysis reveals tumor immune contexture associated with clinical outcomes after CAR T cell therapy;Molecular Therapy;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3